| Product Code: ETC5242382 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
Latvia`s aminoglycosides import market in 2024 continued to be dominated by top exporting countries such as China, India, Denmark, Netherlands, and Belgium. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market structure. Despite a strong compound annual growth rate (CAGR) of 9.87% from 2020 to 2024, the negative growth rate of -34.6% from 2023 to 2024 suggests a potential slowdown or fluctuation in the market dynamics. Monitoring shifts in import trends and market competition will be crucial for stakeholders in the aminoglycosides industry.

By 2027, Latvia's Aminoglycosides market is forecasted to achieve a stable growth rate of 0.52%, with Germany leading the Europe region, followed by United Kingdom, France, Italy and Russia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Aminoglycosides Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Aminoglycosides Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Aminoglycosides Market - Industry Life Cycle |
3.4 Latvia Aminoglycosides Market - Porter's Five Forces |
3.5 Latvia Aminoglycosides Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Latvia Aminoglycosides Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Latvia Aminoglycosides Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Latvia Aminoglycosides Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Latvia |
4.2.2 Rising awareness about the effectiveness of aminoglycosides in treating severe infections |
4.2.3 Growing investments in healthcare infrastructure and facilities in Latvia |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines for the use of aminoglycosides |
4.3.2 Rising concerns about antibiotic resistance and side effects associated with aminoglycosides |
5 Latvia Aminoglycosides Market Trends |
6 Latvia Aminoglycosides Market Segmentations |
6.1 Latvia Aminoglycosides Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Latvia Aminoglycosides Market Revenues & Volume, By Neomycin, 2021-2031F |
6.1.3 Latvia Aminoglycosides Market Revenues & Volume, By Tobramycin, 2021-2031F |
6.1.4 Latvia Aminoglycosides Market Revenues & Volume, By Gentamicin, 2021-2031F |
6.1.5 Latvia Aminoglycosides Market Revenues & Volume, By Amikacin, 2021-2031F |
6.1.6 Latvia Aminoglycosides Market Revenues & Volume, By Paromomycin, 2021-2031F |
6.1.7 Latvia Aminoglycosides Market Revenues & Volume, By Streptomycin, 2021-2031F |
6.1.9 Latvia Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.1.10 Latvia Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.2 Latvia Aminoglycosides Market, By Route of Administration |
6.2.1 Overview and Analysis | 6.2.2 Latvia Aminoglycosides Market Revenues & Volume, By Injectables (Parenteral), 2021-2031F |
6.2.3 Latvia Aminoglycosides Market Revenues & Volume, By Feed, 2021-2031F |
6.2.4 Latvia Aminoglycosides Market Revenues & Volume, By Intra-mammary, 2021-2031F |
6.2.5 Latvia Aminoglycosides Market Revenues & Volume, By Topical, 2021-2031F |
6.2.6 Latvia Aminoglycosides Market Revenues & Volume, By Oral, 2021-2031F |
6.3 Latvia Aminoglycosides Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Latvia Aminoglycosides Market Revenues & Volume, By Veterinary, 2021-2031F |
6.3.3 Latvia Aminoglycosides Market Revenues & Volume, By Skin Infection, 2021-2031F |
6.3.4 Latvia Aminoglycosides Market Revenues & Volume, By Respiratory diseases, 2021-2031F |
6.3.5 Latvia Aminoglycosides Market Revenues & Volume, By UTI & Pelvic Diseases, 2021-2031F |
6.3.6 Latvia Aminoglycosides Market Revenues & Volume, By Other diseases, 2021-2031F |
7 Latvia Aminoglycosides Market Import-Export Trade Statistics |
7.1 Latvia Aminoglycosides Market Export to Major Countries |
7.2 Latvia Aminoglycosides Market Imports from Major Countries |
8 Latvia Aminoglycosides Market Key Performance Indicators |
8.1 Number of healthcare facilities adopting aminoglycosides in their treatment protocols |
8.2 Rate of prescription of aminoglycosides by healthcare professionals in Latvia |
8.3 Patient adherence to aminoglycoside treatment regimens |
9 Latvia Aminoglycosides Market - Opportunity Assessment |
9.1 Latvia Aminoglycosides Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Latvia Aminoglycosides Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Latvia Aminoglycosides Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Latvia Aminoglycosides Market - Competitive Landscape |
10.1 Latvia Aminoglycosides Market Revenue Share, By Companies, 2024 |
10.2 Latvia Aminoglycosides Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here